Published in Lancet on April 22, 2000
Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax (2001) 3.23
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
Stepping down inhaled corticosteroids in asthma: randomised controlled trial. BMJ (2003) 1.76
Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics (2008) 1.48
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol (2009) 1.40
Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease. Br J Clin Pharmacol (2003) 1.36
Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax (2003) 1.19
Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol (2010) 1.16
Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax (2001) 1.14
A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol (2003) 1.00
Systemic effects of inhaled corticosteroids: an overview. Open Respir Med J (2014) 0.97
Racial variations in antiresorptive medication use: results from the 2000 Medical Expenditure Panel Survey (MEPS). Osteoporos Int (2005) 0.97
Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax (2004) 0.97
Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. Br J Clin Pharmacol (2007) 0.87
Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review. Integr Blood Press Control (2011) 0.84
Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period. J Cyst Fibros (2015) 0.82
The ISOLDE trial. Side effects with inhaled steroids should not be forgotten. BMJ (2000) 0.81
Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-Analysis. PLoS One (2015) 0.81
Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids. Clinics (Sao Paulo) (2009) 0.81
Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment. Eur Spine J (2006) 0.80
Medical treatment of vertebral osteoporosis. Eur Spine J (2003) 0.80
TRIP-1: a regulator of osteoblast function. J Bone Miner Res (2012) 0.79
Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. Clin Rheumatol (2006) 0.78
Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma. Allergy Asthma Clin Immunol (2005) 0.78
Inhaled corticosteroids, bone density, and risk of fracture. Lancet (2000) 0.77
Relative contributions of multiple determinants to bone mineral density in men. Osteoporos Int (2009) 0.77
Self-reported osteoporosis prevention in inhaled corticosteroid users in community pharmacy setting. SAGE Open Med (2015) 0.76
Inhaled corticosteroids and bone density. Lancet (2000) 0.75
Prescribing for osteoporosis following the use of inhaled and oral glucocorticoids in general practice. Br J Clin Pharmacol (2004) 0.75
Inhaled corticosteroids and bone density. Lancet (2000) 0.75
Pharmacotherapy in the management of asthma in the elderly: a review of clinical studies. Asia Pac Allergy (2016) 0.75
Inhaled corticosteroids and bone density. Lancet (2000) 0.75
Inhaled corticosteroids and bone density. Lancet (2000) 0.75
Randomized trial of acupoints herbal patching in Sanfu Days for asthma in clinical remission stage. Clin Transl Med (2016) 0.75
Metabolomics analysis identifies different metabotypes of asthma severity. Eur Respir J (2017) 0.75
The Skeletal Effects of Inhaled Glucocorticoids. Curr Osteoporos Rep (2016) 0.75
Inhaled corticosteroids and bone density. Lancet (2000) 0.75
Cross-sectional study on bone density-related sonographic parameters in children with asthma: correlation to therapy with inhaled corticosteroids and disease severity. J Bone Miner Metab (2008) 0.75
Value of basal serum cortisol to detect corticosteroid-induced adrenal insufficiency in elite cyclists. Eur J Appl Physiol (2006) 0.75
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax (2003) 9.54
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ (2001) 6.32
Emergency care in general practice. BMJ (1995) 5.94
Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet (1988) 4.85
Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax (2008) 4.78
Large computer databases in general practice. BMJ (1991) 4.58
Asthma, wheezing, and school absence in primary schools. Arch Dis Child (1989) 4.57
Evolutionary history of a multigene family: an expressed human beta-tubulin gene and three processed pseudogenes. Cell (1983) 4.26
Randomised controlled trials in general practice. BMJ (1995) 3.95
General practitioner training in paediatrics in the Trent region. BMJ (1989) 3.90
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet (2004) 3.89
Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax (2004) 3.77
The new agenda for general practice computing. BMJ (1990) 3.67
Revalidation in the United Kingdom: general principles based on experience in general practice. BMJ (1999) 3.58
Consultation patterns and provision of contraception in general practice before teenage pregnancy: case-control study. BMJ (2000) 3.41
Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the U.K.: implications for developing management guidelines. Respir Med (1997) 3.38
Symptoms, signs, and prescribing for acute lower respiratory tract illness. Br J Gen Pract (2001) 3.35
Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell (1998) 3.33
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut (2003) 3.30
Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax (2001) 3.23
Identification of two human beta-tubulin isotypes. Mol Cell Biol (1983) 3.15
Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J (1989) 3.12
Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax (1987) 3.06
Timer: a new objective measure of consultation content and its application to computer assisted consultations. Br Med J (Clin Res Ed) (1986) 3.00
Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med (1969) 2.99
Explaining variations in prescribing costs across England. BMJ (1993) 2.99
Do single handed practices offer poorer care? Cross sectional survey of processes and outcomes. BMJ (2001) 2.97
Living near a main road and the risk of wheezing illness in children. Am J Respir Crit Care Med (2001) 2.94
A counsellor in every practice? BMJ (1993) 2.88
Promoting patient safety in primary care. BMJ (2001) 2.85
Greeks bearing gifts. Br Med J (Clin Res Ed) (1987) 2.82
The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med (2002) 2.78
Computer assisted screening: effect on the patient and his consultation. Br Med J (Clin Res Ed) (1985) 2.76
Novel antibiotic resistance transfer in Bacteroides. Antimicrob Agents Chemother (1982) 2.70
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Prion protein is necessary for normal synaptic function. Nature (1994) 2.69
Association between teenage pregnancy rates and the age and sex of general practitioners: cross sectional survey in Trent 1994-7. BMJ (2000) 2.58
Transferable tetracycline resistance in Clostridium difficile. Antimicrob Agents Chemother (1981) 2.56
The Shipman inquiry: implications for the public's trust in doctors. Br J Gen Pract (2000) 2.55
General practice workload implications of the national service framework for coronary heart disease: cross sectional survey. BMJ (2001) 2.55
The quality divide in primary care. BMJ (1989) 2.52
Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet (1990) 2.52
Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet (2001) 2.51
Sequence of a cDNA clone encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. Proc Natl Acad Sci U S A (1984) 2.51
Computers in the surgery. The patient's view. Br Med J (Clin Res Ed) (1984) 2.43
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry (2005) 2.41
Insulin activates a tyrosine-specific protein kinase in extracts of 3T3-L1 adipocytes and human placenta. Proc Natl Acad Sci U S A (1982) 2.40
Depression as a risk factor for ischaemic heart disease in men: population based case-control study. BMJ (1998) 2.38
Genetic and biochemical analysis of a novel Ambler class A beta-lactamase responsible for cefoxitin resistance in Bacteroides species. Antimicrob Agents Chemother (1993) 2.35
The microtubule binding domain of microtubule-associated protein MAP1B contains a repeated sequence motif unrelated to that of MAP2 and tau. J Cell Biol (1989) 2.34
HINDERED CIS ISOMERS OF VITAMIN A AND RETINENE: THE STRUCTURE OF THE NEO-B ISOMER. Proc Natl Acad Sci U S A (1955) 2.33
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. BMJ (2008) 2.32
The cost-effectiveness of lipid lowering in patients with ischaemic heart disease: an intervention and evaluation in primary care. Br J Gen Pract (2000) 2.31
Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med (1996) 2.29
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med (1994) 2.26
Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med (1995) 2.25
Sleep nasendoscopy: a technique of assessment in snoring and obstructive sleep apnoea. Clin Otolaryngol Allied Sci (1991) 2.25
Do minutes count? Consultation lengths in general practice. J Health Serv Res Policy (1998) 2.23
Are spouses of patients with hypertension at increased risk of having hypertension? A population-based case-control study. Br J Gen Pract (1998) 2.21
Assessment and management of asthma in an accident and emergency department. Thorax (1985) 2.21
Genetics, evolution, and expression of the 68,000-mol-wt neurofilament protein: isolation of a cloned cDNA probe. J Cell Biol (1985) 2.20
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ (1996) 2.19
The Synthesis of Rhodopsin from Vitamin A(1). Proc Natl Acad Sci U S A (1950) 2.16
Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum (1992) 2.14
Sudden death in asthma: discussion paper. J R Soc Med (1983) 2.13
Analysis of cepA and other Bacteroides fragilis genes reveals a unique promoter structure. FEMS Microbiol Lett (2000) 2.12
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol (1983) 2.10
Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. J Infect Dis (2006) 2.09
Characterization of Bacteroides ovatus plasmid pBI136 and structure of its clindamycin resistance region. J Bacteriol (1985) 2.09
Assessing the consultation: methods of observing trainees in general practice. Br Med J (Clin Res Ed) (1984) 2.09
Six mouse alpha-tubulin mRNAs encode five distinct isotypes: testis-specific expression of two sister genes. Mol Cell Biol (1986) 2.07
Large transmissible clindamycin resistance plasmid in Bacteroides ovatus. J Bacteriol (1984) 2.06
Development and use of cloning systems for Bacteroides fragilis: cloning of a plasmid-encoded clindamycin resistance determinant. J Bacteriol (1985) 2.06
What symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease. Int J Epidemiol (1989) 2.05
The chemistry of visual photoreception. Cold Spring Harb Symp Quant Biol (1965) 2.04
ADH action: evidence for a membrane shuttle mechanism. Ann N Y Acad Sci (1981) 2.03
Free intermingling of mammalian beta-tubulin isotypes among functionally distinct microtubules. Cell (1987) 2.02
Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med (1999) 2.02
Inequalities in access to coronary angiography and revascularisation: the association of deprivation and location of primary care services. Br J Gen Pract (2000) 2.01
Response to inhaled histamine and 24 hour sodium excretion. Br Med J (Clin Res Ed) (1986) 2.01
Bronchoprotective role for endogenous prostaglandin E2. Lancet (1995) 2.01
Association between a GABRB3 polymorphism and autism. Mol Psychiatry (2002) 2.00
Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional survey. Lancet (2004) 1.98
The mammalian beta-tubulin repertoire: hematopoietic expression of a novel, heterologous beta-tubulin isotype. J Cell Biol (1986) 1.97
Tubulin subunits exist in an activated conformational state generated and maintained by protein cofactors. J Cell Biol (1997) 1.97
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med (1984) 1.95
Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A beta-lactamases. Antimicrob Agents Chemother (1993) 1.94
beta-adrenergic agonist resistance in normal human airways. Lancet (1977) 1.91
Otitis externa in UK general practice: a survey using the UK General Practice Research Database. Br J Gen Pract (2001) 1.89
A pilot study of a randomized controlled trial of pragmatic eradication of Helicobactor pylori in primary care. Br J Gen Pract (1997) 1.88
Association of CCR5 delta32 with reduced risk of asthma. Lancet (1999) 1.88
Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Thorax (2004) 1.86
Estimation and repeatability of the response to inhaled histamine in a community survey. Thorax (1987) 1.85